Kasper Rousøe, CFO of Qlife presents at Redeye Life Science Day 2022.

On November 24th at 14:20 Qlife's CFO, Kasper Boel Rousøe will presentthe latest developments in the company at Redeye. We will do an in-depth interview, called InFocus. The interview will be broadcasted live at https://www.redeye.se/events/850947/redeye-life-science-day, where you also will find our pre-recorded presentation, called Slides and the replay afterwards. Take your chance to ask questions directly to us via the form on the event page.
 

For more information please contact:

Kasper Boel Rousøe, CFO
kbr@egoo.health
+45 26 72 27 40

Qlife is a medical device company born to challenge the status quo in healthcare. We work to shift the perspective and turn today's view on healthcare into tomorrow's focus on health- empowerment. We are on a quest to empower people with more accessible ways to understand their health - so that they can move beyond reactive care towards proactive wellbeing. It's how we contribute to improving quality of life for every individual and for the greater society.

Shares for Qlife are being traded on Nasdaq First North Growth Market in Stockholm with G&W Fondkommission as certified advisor (phone: +46 (0) 8-503 000 50, e-mail: ca@gwkapital.se).
Read more on Egoo.health, Qlifeholding.com or follow us on LinkedIn.